Warman Meir, Granot Esther, Halperin Doron
Department of Otolaryngology Head and Neck Surgery, Kaplan Medical Center, POB 1, Rehovot 76100, Israel.
Ear Nose Throat J. 2015 Jun;94(6):220;222;224-7. doi: 10.1177/014556131509400607.
Chronic rhinitis (CR) is a common disorder in children. Allergic rhinitis (AR) is a risk factor for CR, and children with AR tend to suffer more from hypertrophic adenoids than do patients with nonallergic rhinitis (NAR). Few studies have addressed the issue of alleviating symptoms of pediatric CR or AR following adenoidectomy alone. We conducted a retrospective chart review to determine whether CR in children improves after adenoidectomy and whether children with AR will benefit more than those with NAR. Charts of 47 children who had undergone adenoidectomy for nasal obstruction and chronic middle ear effusion were reviewed. AR and NAR subgroups were classified based on symptoms, signs, blood IgE, and nasal smear (allergic criteria). Hypertrophic adenoids were graded using the adenoid-to-nasopharyngeal ratio (ANr >0.8). A questionnaire was used to assess the change in chronic rhinitis postoperatively. Improvement in CR was reported in 37 of 47 (79%) children. Patients with AR improved to a higher extent than those with NAR (12 of 14 [86%] vs. 25 of 33 [76%], respectively), but the difference was not statistically significant. A total of 41 lateral postoperative nasopharyngeal x-rays were obtained. The x-rays revealed that 20 of 26 (77%) of patients with ANr >0.8 had complete and 4 of 26 (15%) had partial resolution of symptoms of CR for a total resolution rate of 92%, compared to only a 53% resolution in the ANr <0.8 subgroup (6 of 15 and 2 of 15 patients, respectively [p <0.05]). The correlation between adenoid size and resolution of CR was not related to any of the AR/NAR subgroups. We conclude that symptoms of CR may improve after adenoidectomy in children who are experiencing nasal obstruction and chronic otitis media with effusion. Clinical improvement did not differ between AR and NAR patients, and was more prominent in children with hypertrophic adenoids (ANr >0.8).
慢性鼻炎(CR)是儿童常见的疾病。变应性鼻炎(AR)是CR的一个危险因素,与非变应性鼻炎(NAR)患者相比,AR患儿更易患腺样体肥大。很少有研究探讨单纯腺样体切除术后缓解小儿CR或AR症状的问题。我们进行了一项回顾性病历审查,以确定儿童CR在腺样体切除术后是否改善,以及AR患儿是否比NAR患儿受益更多。回顾了47例因鼻塞和慢性中耳积液接受腺样体切除术的儿童病历。根据症状、体征、血液免疫球蛋白E(IgE)和鼻涂片(变应性标准)对AR和NAR亚组进行分类。使用腺样体与鼻咽部比值(ANr>0.8)对腺样体肥大进行分级。采用问卷调查评估术后慢性鼻炎的变化。47例患儿中有37例(79%)报告CR有所改善。AR患者的改善程度高于NAR患者(分别为14例中的12例[86%]和33例中的25例[76%]),但差异无统计学意义。共获得41张术后鼻咽侧位X线片。X线片显示,ANr>0.8的患者中,26例中有20例(77%)CR症状完全缓解,26例中有4例(15%)部分缓解,总缓解率为92%,而ANr<0.8亚组的缓解率仅为53%(分别为15例中的6例和15例中的2例[p<0.05])。腺样体大小与CR缓解之间的相关性与任何AR/NAR亚组均无关。我们得出结论,对于有鼻塞和慢性中耳积液的儿童,腺样体切除术后CR症状可能改善。AR和NAR患者的临床改善无差异,在腺样体肥大(ANr>0.8)的儿童中更明显。